Obesity drug study pulled before it even started
NCT ID NCT06970405
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This study was designed to test the safety of an experimental drug called garetosmab in men and post-menopausal women with obesity who are otherwise healthy. Researchers planned to measure how the drug affects blood clotting, hormone levels, and whether the body makes antibodies against it. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.